Oncology · Phase II

Top sponsors

• First People's Hospital 261 programs
• Chinese Academy of 198 programs
• George Institute for 118 programs
• United Therapeutics Europe 112 programs
• Telethon Foundation 91 programs
• Takeda 79 programs
• Regeneron UK 71 programs
• MSD Merck Sharp 63 programs
• Ningbo Cancer Hospital 62 programs
• Anaxis Pharma 57 programs
• AstraZeneca 52 programs
• HOFFMANN-LA ROCHE 50 programs

1. NOV-002

   Cellectar Biosciences

   Leukemia

   phase 2 · small molecule · terminated

   1 trial →

2. NP30179

   Hoffmann-La Roche

   Relapsed/refractory B-cell non-Hodgkin’s lymphoma (r/r NHL)

   phase 2 · small molecule · active

   1 trial →

3. NP39488

   Hoffmann-La Roche

   Relapsed/refractory (r/r) B-cell Non-Hodgkin’s Lymphoma (NHL)

   phase 2 · other · active

   1 trial →

4. NPC-1C/NEO-102

   Chongqing Precision Biotech Co., Ltd

   Metastatic Pancreatic Cancer

   phase 2 · small molecule · completed

   1 trial →

5. NRX 194204

   IO Biotech

   Castration Resistant Prostate Cancer

   phase 2 · small molecule · completed

   1 trial →

6. NT219

   PURPLE BIOTECH LTD.

   Head and Neck Cancer

   phase 2 · small molecule · active

   1 trial →

7. NT219

   PURPLE BIOTECH LTD.

   Solid Tumor, Adult

   phase 2 · small molecule · completed

   1 trial →

8. NX-5948

   Nurix Therapeutics

   Chronic Lymphocytic Leukemia (CLL)

   phase 2 · small molecule · active

   2 trials →

9. NX-5948

   Nurix Therapeutics

   Relapsed/Refractory (R/R) Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

   phase 2 · small molecule · active

   1 trial →

10. NY-ESO-1 Peptide vaccine

    Coherus Oncology

    Ovarian Cancer Stage IV

    phase 2 · mab · active

    1 trial →

11. NY-ESO-1(TCR Affinity Enhancing Specific T cell Therapy)

    Chongqing Precision Biotech Co., Ltd

    Soft Tissue Sarcoma

    phase 2 · mab · active

    1 trial →

12. Nab paclitaxel

    BRIGHT MINDS BIOSCIENCES INC.

    Metastatic Pancreatic Cancer

    phase 2 · small molecule · terminated

    1 trial →

13. Nab-PIPAC

    Fondazione Telethon ETS

    Pancreatic cancer with peritoneal metastases

    phase 2 · small molecule · active

    1 trial →

14. Nab-paclitaxel

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Head and Neck Squamous Cell Carcinoma

    phase 2 · small molecule · completed

    1 trial →

15. Nab-paclitaxel Combined With Cadonilimab (AK104)

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Gastric Cancer

    phase 2 · small molecule · active

    1 trial →

16. Nadunolimab

    Coherus Oncology

    Metastatic Microsatellite Stable Colorectal Carcinoma

    phase 2 · small molecule · active

    1 trial →

17. Namodenoson 25mg

    Can-Fite BioPharma

    Pancreatic Adenocarcinoma

    phase 2 · small molecule · active

    1 trial →

18. Nenocorilant 200 mg

    CORCEPT THERAPEUTICS INC

    Neoplasms

    phase 2 · small molecule · active

    1 trial →

19. NeoART

    The George Institute

    HER2 positive resectable esophagogastric adenocarcinoma

    phase 2 · small molecule · active

    1 trial →

20. NeoMatryx

    The George Institute

    Merkel Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

21. Neoadjuvant Chemotherapy

    Xiangya Hospital of Central South University

    High-Grade Upper Tract Urothelial Carcinoma

    phase 2 · small molecule · completed

    1 trial →

22. Neoadjuvant Chemotherapy (NACT)

    The First People's Hospital of Lianyungang

    HR+/HER2- Breast Cancer

    phase 2 · small molecule · active

    1 trial →

23. Neoadjuvant Chemotherapy combined with Neoadjuvant Radiotherapy

    The First People's Hospital of Lianyungang

    Breast Cancer

    phase 2 · other · active

    1 trial →

24. Neoadjuvant Sugemalimab + Chemotherapy Followed by Adjuvant Sugemalimab

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Lung Cancer (NSCLC)

    phase 2 · small molecule · active

    1 trial →

25. Neoadjuvant Therapy

    The First People's Hospital of Lianyungang

    Gastric Cancer

    phase 2 · other · active

    1 trial →

26. Neoadjuvant therapy: TCbHPy

    The First People's Hospital of Lianyungang

    Breast Cancer

    phase 2 · other · active

    1 trial →

27. Neoantigen specific TCR-T cell drug product

    Alaunos Therapeutics

    Gynecologic Cancer

    phase 2 · mab · terminated

    1 trial →

28. Neratinib

    PUMA BIOTECHNOLOGY, INC.

    GastroEsophageal Cancer

    phase 2 · small molecule · active

    1 trial →

29. Neratinib

    PUMA BIOTECHNOLOGY, INC.

    Early-stage Breast Cancer

    phase 2 · small molecule · active

    1 trial →

30. Neratinib

    PUMA BIOTECHNOLOGY, INC.

    Triple Negative Breast Cancer

    phase 2 · small molecule · active

    1 trial →

31. Neratinib

    PUMA BIOTECHNOLOGY, INC.

    Solid Tumors Harboring Somatic HER2 or EGFR Exon 18 Mutations

    phase 2 · small molecule · terminated

    1 trial →

32. Neratinib

    PUMA BIOTECHNOLOGY, INC.

    Solid Tumor, Adult

    phase 2 · small molecule · active

    1 trial →

33. Neratinib

    PUMA BIOTECHNOLOGY, INC.

    Metastatic Prostate Adenocarcinoma

    phase 2 · small molecule · terminated

    1 trial →

34. Neratinib

    PUMA BIOTECHNOLOGY, INC.

    Metastatic Breast Cancer

    phase 2 · small molecule · terminated

    1 trial →

35. Neratinib

    PUMA BIOTECHNOLOGY, INC.

    HER2-positive Breast Cancer

    phase 2 · small molecule · completed

    1 trial →

36. Neratinib

    PUMA BIOTECHNOLOGY, INC.

    HER2 Amplified Breast Cancer

    phase 2 · small molecule · completed

    1 trial →

37. Neratinib

    PUMA BIOTECHNOLOGY, INC.

    Early Stage HER2+ Breast Cancer

    phase 2 · small molecule · completed

    1 trial →

38. Neratinib

    PUMA BIOTECHNOLOGY, INC.

    Anatomic Stage I Breast Cancer

    phase 2 · small molecule · active

    1 trial →

39. Neratinib

    PUMA BIOTECHNOLOGY, INC.

    Advanced Breast Cancer

    phase 2 · small molecule · completed

    1 trial →

40. Neratinib

    PUMA BIOTECHNOLOGY, INC.

    Breast Cancer

    phase 2 · small molecule · completed

    8 trials →

41. Nilotinib followed by treatment-free

    Novartis Pharmaceuticals

    Chronic Myelogenous Leukemia

    phase 2 · small molecule · completed

    1 trial →

42. Nimotuzumab

    The First People's Hospital of Lianyungang

    Esophageal Squamous Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

43. Nimotuzumab

    The First People's Hospital of Lianyungang

    Esophageal Neoplasms

    phase 2 · small molecule · active

    1 trial →

44. Nimotuzumab

    Chinese University of Hong Kong

    Esophageal Cancer

    phase 2 · small molecule · completed

    1 trial →

45. Nimotuzumab + SHR-1210

    The First People's Hospital of Lianyungang

    Esophageal Squamous Cell Carcinoma

    phase 2 · small molecule · active

    1 trial →

46. Nimotuzumab combined with chemoradiotherapy

    The First People's Hospital of Lianyungang

    Pancreatic Cancer Non-resectable

    phase 2 · small molecule · active

    1 trial →

47. Niraparib

    Xiyuan Hospital of China Academy of Chinese Medical Sciences

    Ovarian Cancer

    phase 2 · small molecule · active

    1 trial →

48. Niraparib

    Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University

    Platinum-resistant Recurrent Clear Cell Ovarian Cancer

    phase 2 · small molecule · completed

    1 trial →

Frequently asked questions